S. 1388: Prescription Pricing for the People Act of 2021
CBO Score
$2 million
Documentation
Date of Report
Thu January 13th, 2022
CBO Report Details
Legislation Details
117th Congress
A bill to require the Federal Trade Commission to study the role of intermediaries in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other purposes.
Sponsor: Sen. Charles Grassley — R — IA
Requires the Federal Trade Commission (FTC) to report about anticompetitive practices and other trends within the pharmaceutical supply chain that may impact the cost of prescriptions drugs. The FTC also must provide recommendations to increase transparency in the supply chain and prevent anticompetitive practices.
JOIN US!
Sign up below to receive updates when your Members of Congress vote for new spending increases or cuts.
Lost your Password?
Don't be sad- we've got your back. Just enter your email below and instructions on resetting your password will be sent to you.
×